相关实验视频

Updated: May 15, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

比总和更重要的是:血管内皮生长因子抑制如何释放免疫检查点封锁的全部潜力

Daniel H Shu¹, Mark Yarchoan²

¹Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.

|April 9, 2025

概括

与免疫检查点抑制剂 (ICI) 结合的抗血管性疗法在固体瘤中显示出有前途. 这项研究表明,抗血管内皮生长因子治疗使调节性T细胞更容易受到伤害,从而提高ICI的有效性.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

抗血管生成疗法和免疫检查点抑制剂 (ICI) 的结合是治疗固体瘤的活跃研究领域.
这些联合治疗的协同效应背后的精确机制尚未完全理解.

研究的目的:

阐明抗血管生成疗法在固体瘤中增强免疫检查点抑制剂疗效的机制.

主要方法:

研究了抗血管内皮生长因子 (抗VEGF) 治疗对瘤微环境中的调节性T细胞 (Tregs) 的影响.
评估了VEGF通路抑制对Treg功能和ICI响应性的影响.

主要成果:

发现抗VEGF治疗对调节性T细胞 (Tregs) 重编程,使其变得更加脆弱.
这种通过抗VEGF治疗对Tregs的重编程增强了免疫检查点抑制剂的抗瘤活性.

结论:

这项研究发现了一种新的机制,即抗血管生成疗法,特别是抗VEGF,通过损害Treg功能来增强ICI的疗效.
这些发现为优化结合癌症免疫疗法用于固体瘤提供了新的见解.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...